Cellectis S.A.
CLLS
$2.90
$0.082.84%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -11.07% | -83.87% | 58.15% | 25.23% | 7.36% |
| Total Depreciation and Amortization | -5.20% | -1.33% | 4.70% | 4.57% | 4.76% |
| Total Amortization of Deferred Charges | 61.87% | 61.87% | 998.55% | 998.55% | 998.55% |
| Total Other Non-Cash Items | 118.83% | 461.33% | -0.74% | 6,256.82% | 177.74% |
| Change in Net Operating Assets | -157.98% | -177.50% | -132.54% | -119.61% | 2.08% |
| Cash from Operations | -229.19% | -271.39% | -146.35% | -164.76% | 247.68% |
| Capital Expenditure | 19.20% | 8.63% | -5.28% | -9.80% | -156.03% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 59.86% | 72.94% | 32.13% | 66.17% | -461.08% |
| Cash from Investing | 58.70% | 71.32% | 31.27% | 65.02% | -442.60% |
| Total Debt Issued | -- | -- | -61.12% | -70.07% | -84.87% |
| Total Debt Repaid | -7.69% | -0.81% | 2.98% | 2.98% | 2.52% |
| Issuance of Common Stock | -99.91% | -99.95% | -- | -100.00% | 77.90% |
| Repurchase of Common Stock | -- | -- | -- | 99.93% | 99.93% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 28.50% | 27.74% | 74.20% | 30.72% | -512.83% |
| Cash from Financing | -124.03% | -118.81% | -107.59% | -107.22% | -2.47% |
| Foreign Exchange rate Adjustments | 314.26% | 242.73% | -47.18% | -277.01% | -1,963.46% |
| Miscellaneous Cash Flow Adjustments | -100.00% | -100.00% | 250.00% | 100.00% | 200.00% |
| Net Change in Cash | -2,089.17% | -1,348.94% | -216.48% | -238.01% | -87.53% |